Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Products ETF
  • Pininvest Analysis

About - Virtus Investment Partners VRTS/NASDAQ is a premier provider of investment solutions to individuals, financial advisors, and institutions. We aim to offer distinguished strategies and original perspectives to help our clients achieve better outcomes

Virtus ETF Solutions is an industry leader in subadvised exchange traded funds

Virtus LifeSci Biotech Products ETF  BBP/NYSEARCA invests in products stage companies, which are typically more established companies with much clinical trial failure risk behind them. They have already successfully completed multiple human clinical trials and have received FDA approval to sell and market a drug

LifeSci Index Partners, LLC is a New York-based index provider of healthcare-based stock market indices. The LifeSci team is comprised of investment professionals with experience in biotechnology equity research, in organic chemistry research in academia, and at pharmaceutical and biotechnology companies

Note from DATAvariance
The complete list of the 38 BBP constituents on the theme are not weighted; performance and volatility are calculated for informative purpose only - assuming one share of each component had been invested at the beginning of the selected period

For actual performance of the fund, which maybe higher or lower, depending on the weighting and trades decided by the provider, please check the information available on the Virtus LifeSci Biotech Products ETF site or contact your advisor

More about Virtus LifeSci Biotech Products ETF

Virtus LifeSci Biotech Products ETF • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
ACADIA Pharmaceuticals Inc ACAD NASDAQ Health Care Drug Manufacturers - Diversified USD 25.96 3.7 B 46.7% 67%   7% -38%
Acorda Therapeutics Inc ACOR NASDAQ Health Care Biopharmaceuticals USD 10.16 484 M -58.0% 65%   1% -69%
Alexion Pharmaceuticals Inc. ALXN NASDAQ Health Care Biopharmaceuticals USD 127.15 29 B 8.0% 34%   3% -32%
Amgen Inc. AMGN NASDAQ Health Care Biopharmaceuticals USD 171.28 104 B -0.8% 22%   1% -20%
Biogen Inc BIIB NASDAQ Health Care Biopharmaceuticals USD 227.06 45 B -20.7% 49%   2% -44%
BioMarin Pharmaceutical BMRN NASDAQ Health Care Biopharmaceuticals USD 89.07 16 B -3.7% 34%   3% -24%
Celgene CELG NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 95.24 67 B 21.1% 34%   2% -37%
Clovis Oncology, Inc. CLVS NASDAQ Health Care Biopharmaceuticals USD 16.74 887 M -65.6% 77%   1% -76%
Dynavax Technologies DVAX NASDAQ Health Care Biopharmaceuticals USD 5.78 370 M -65.5% 60%   1% -65%
Enanta Pharmaceuticals Inc ENTA NASDAQ Health Care Biopharmaceuticals USD 94.45 1.9 B -2.1% 52%   3% -48%
Exelixis EXEL NASDAQ Health Care Biopharmaceuticals USD 20.36 6.1 B -2.3% 48%   3% -39%
Gilead Sciences Inc. GILD NASDAQ Health Care Biopharmaceuticals USD 66.89 85 B 2.7% 24%   2% -23%
Halozyme Therapeutics HALO NASDAQ Health Care Biopharmaceuticals USD 15.41 2.2 B -16.3% 39%   3% -32%
Incyte Corporation INCY NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 81.75 17 B 19.5% 35%   3% -21%
Intercept Pharmaceuticals ICPT NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 87.83 2.6 B 23.6% 60%   5% -34%
Ionis Pharmaceuticals IONS NASDAQ Health Care Biopharmaceuticals USD 64.72 9.1 B 44.3% 47%   4% -25%
Ironwood Pharmaceuticals IRWD NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 11.08 1.7 B -22.6% 58%   2% -56%
Lexicon Pharmaceuticals LXRX NASDAQ Health Care Diabetes USD 5.92 629 M -38.4% 71%   2% -68%
Ligand Pharmaceuticals LGND NASDAQ Health Care Clinical trial work USD 113.38 2.2 B -40.1% 46%   2% -61%
Medicines Co MDCO NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 34.88 2.6 B 6.0% 44%   3% -58%
Momenta Pharmaceuticals Inc MNTA NASDAQ Health Care Biopharmaceuticals USD 12.26 1.2 B -46.8% 63%   2% -67%
Nektar Therapeutics NKTR NASDAQ Health Care Clinical trial work USD 33.79 5.9 B -57.7% 79%   1% -66%
Neurocrine Biosciences NBIX NASDAQ Health Care Biopharmaceuticals USD 79.89 7.3 B -15.2% 46%   3% -46%
Omeros Corp OMER NASDAQ Health Care Biopharmaceuticals USD 17.86 876 M -9.4% 85%   4% -60%
Portola Pharmaceuticals PTLA NASDAQ Health Care Biopharmaceuticals USD 30.44 2.1 B -25.5% 62%   3% -65%
Puma Biotechnology PBYI NASDAQ Health Care Biopharmaceuticals USD 15.45 597 M -70.2% 105%   1% -76%
Radius Health RDUS NASDAQ Health Care Biopharmaceuticals USD 21.11 973 M -27.6% 57%   3% -58%
Regeneron Pharmaceuticals Inc. REGN NASDAQ Health Care Biopharmaceuticals USD 312.56 34 B 6.4% 32%   3% -31%
Retrophin RTRX NASDAQ Health Care Biopharmaceuticals USD 18.80 779 M -35.0% 44%   2% -44%
Sarepta Therapeutics, Inc. SRPT NASDAQ Health Care Biopharmaceuticals USD 120.84 9.0 B 31.8% 61%   6% -40%
Seattle Genetics Inc. SGEN NASDAQ Health Care Biopharmaceuticals USD 69.14 11 B 23.9% 43%   4% -37%
Spark Therapeutics ONCE NASDAQ Health Care Biopharmaceuticals USD 110.33 4.2 B 40.7% 97%   7% -62%
Theravance Biopharma, Inc. TBPH NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 18.18 1.0 B -23.3% 44%   2% -48%
United Therapeutics UTHR NASDAQ Health Care Biopharmaceuticals USD 87.50 3.8 B -15.5% 33%   2% -34%
Vanda Pharmaceuticals Inc. VNDA NASDAQ Health Care Drug Manufacturers - Diversified USD 16.28 857 M -5.6% 55%   3% -53%
Vertex Pharmaceuticals VRTX NASDAQ Health Care Biopharmaceuticals USD 171.77 44 B 9.1% 33%   3% -21%